AMEX · LABU
Financial Services · Asset Management
$331.23
Down-$0.36 (-0.11%)
Updated Aug 28, 2026, 4:55 AM
SID Score
5.7/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 21 trading sessions · Daily adjusted prices
LABU closed at $331.23 after 21 trading sessions, up 33.14% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 27, 2026 | $328.13 | $336.2443 | $322.40 | $331.23 | 207.66K |
| Aug 26, 2026 | $329.67 | $335.50 | $320.25 | $331.59 | 345.87K |
| Aug 25, 2026 | $317.82 | $340.1999 | $317.82 | $335.54 | 457.66K |
| Aug 24, 2026 | $314.79 | $315.40 | $293.00 | $308.33 | 355.17K |
| Aug 21, 2026 | $311.70 | $329.2026 | $306.27 | $317.20 | 468.52K |
| Aug 20, 2026 | $325.97 | $328.44 | $299.01 | $304.91 | 637.02K |
| Aug 19, 2026 | $318.50 | $341.93 | $314.50 | $341.55 | 726.56K |
| Aug 18, 2026 | $281.27 | $292.65 | $278.40 | $289.98 | 334.12K |
| Aug 17, 2026 | $273.31 | $288.90 | $267.40 | $287.30 | 365.43K |
| Aug 14, 2026 | $269.29 | $277.96 | $259.66 | $276.54 | 323.48K |
| Aug 13, 2026 | $292.00 | $293.50 | $272.21 | $273.91 | 605.34K |
| Aug 12, 2026 | $280.58 | $291.00 | $276.00 | $286.75 | 283.25K |
| Aug 11, 2026 | $282.97 | $285.5693 | $273.96 | $280.67 | 293.86K |
| Aug 10, 2026 | $270.00 | $283.075 | $264.56 | $280.02 | 330.83K |
| Aug 7, 2026 | $273.45 | $279.43 | $264.61 | $277.23 | 450.79K |
| Aug 6, 2026 | $258.22 | $274.10 | $255.68 | $262.31 | 512.55K |
| Aug 5, 2026 | $255.00 | $265.50 | $247.77 | $255.66 | 705.46K |
| Aug 4, 2026 | $234.01 | $251.06 | $231.02 | $249.47 | 392.31K |
| Aug 3, 2026 | $227.01 | $232.00 | $212.565 | $228.04 | 346.61K |
| Jul 31, 2026 | $247.98 | $248.46 | $222.27 | $227.40 | 437.28K |
| Jul 30, 2026 | $231.01 | $250.9345 | $227.2742 | $248.79 | 275.29K |
The latest Smart Investors Daily articles mentioning LABU.
LABU research
Company profile and research snapshot.
The fund invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments and securities of the index, exchange-traded funds ("ETFs") that track the index and other financial instruments that provide daily leveraged exposure to the index or ETFs that track the index. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.
Consensus and target data currently published for this company.
No generated briefing is available yet.
defenseworld.net · Dec 7, 2025
Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU - Get Free Report) shares hit a new 52-week high during mid-day trading on Friday. The company traded as high as $169.50 and last traded at $167.9060, with a volume of 88167 shares changing hands. The stock had previously closed at $166.04. Direxion Daily S&P Biotech
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning LABU.
